Dr Iosif Mendichovszky
Position: Clinical Consultant
Personal home page:
PubMed journal articles - click here
My research is focused on hybrid imaging of tumour angiogenesis with positron emission tomography (PET) and magnetic resonance imaging (MRI) using renal cancer as an in-vivo model. I am the clinical lead for PET imaging using 68Ga-labelled tracers at Cambridge University Hospitals NHS Foundation Trust (Addenbrooke's Hospital) and I am involved in several projects investigating the use of 68Ga-PSMA and 68GA-DOTA-labelled radiopharmaceuticals in various primary and metastatic cancers. My aim is to develop quantitative imaging biomarkers to non-invasively measure tumour perfusion and angiogenesis and ultimately translate these into clinical practice to determine anti-angiogenic therapy response.
kidney cancer; breast cancer; positron emission tomography; magnetic resonance imaging;
Symplectic Elements feed provided by Research Information, University of Cambridge